Lieven Annemans is Professor of Health Economics and Pharmacoepidemiology at the Medical Faculty of Ghent University, Ghent, Belgium and at the Medical faculty of Brussels University (VUB).
Professor Annemans is also Chairman of the Flemish Health Council (an advisory board to the Minister of Public Health); and past President of the International Society of Pharmaco Economics and Outcomes Research (ISPOR).
Professor Annemans’ main interests are decision and epidemiological models, early new technology assessment, retrospective and prospective economic evaluations, and willingness-to-pay assessments. He is the author of the book “Health economics for non-economists: an introduction to the principles, methods and pitfalls of health economic evaluations”.
He has worked on health economic evaluations in 20 different countries, involving a diverse range of therapeutic areas including: cardiovascular diseases, chronic obstructive pulmonary disease, diabetes, gastrointestinal disorders and asthma. He has published >90 papers in peer reviewed journals, presented >250 posters/papers at conferences and has given >250 lectures and trainings on health economic evaluation.